Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
May 12, 2026
United States Antimony (UAMY): +15% in 30 Days and +32% in the Quarter on Critical Minerals Momentum

United States Antimony (UAMY): +15% in 30 Days and +32% in the Quarter on Critical Minerals Momentum

Key Takeaways

  • UAMY stock rose approximately +15% over the past 30 days, driven by heightened demand for antimony amid supply chain concerns and new contract announcements.
  • Over the past quarter, the stock gained around +32%, supported by robust revenue growth reported in fiscal 2025 earnings and expansions in critical minerals operations.
  • Key drivers include a $248 million U.S. Defense Logistics Agency contract, antimony smelter expansions, and tungsten project advancements like the Fostung acquisition.
  • Market sentiment boosted by rare earths and critical minerals trends, with high trading volumes reflecting investor interest in U.S. domestic supply positioning.
  • Recent volatility tied to executive changes, such as interim CFO appointment, but fundamentals remain strong with 163% revenue surge in 2025.

Understanding United States Antimony (UAMY) and Its Market Position

United States Antimony Corporation (UAMY) focuses on mining and processing antimony, a critical mineral essential for flame retardants, batteries, and military applications. The company operates through its Antimony and Zeolite segments, producing antimony oxides, metals, and zeolite products for various industrial uses. From its headquarters in Montana, UAMY smelts antimony ore at facilities in Thompson Falls and holds mining claims across the U.S., Canada, and Mexico.

In my view, UAMY's vertically integrated business model—from mining to refining—positions it well as a domestic supplier, especially with global supply disruptions, particularly from China. This exposure to critical minerals has driven much of the recent stock movement, as geopolitical tensions and U.S. policy shifts emphasize onshore production. While competitors like Perpetua Resources are larger, UAMY's government contracts and cost-effective expansions carve out a niche in antimony trisulfide for defense applications. I also checked this using Tickeron’s AI Screener to see how the stock stacks up against others in the industry.

UAMY Stock Performance: The Last 30 Days and Past Quarter

Looking at the past 30 days, UAMY stock climbed +15%, moving from a close near $9.29 around mid-April to $10.65 more recently. The advance was volatile and trend-driven, featuring sharp rallies from April 30 to May 6 that pushed highs to $12.61, followed by pullbacks on profit-taking. Volumes were notably high, topping 17 million shares on peak days, which highlighted the momentum.

Over the past quarter, shares rose +32%, starting from $8.09 in early February. The performance showed steady uptrends with interruptions like post-earnings dips in March, but it stayed range-bound between $7 and $13 before breaking higher. From what I see, this mirrors broader strength in the critical minerals sector.

Key Drivers Behind UAMY's 30-Day Stock Surge

The +15% gain in the last 30 days came from growing attention to UAMY's role in U.S. critical minerals supply chains. A major catalyst was spillover sentiment from rare earths and tungsten updates, including the Fostung project technical report that confirmed significant inferred resources. This shifted valuation views, with shares jumping 24.7% in a single session.

Other factors included the $106.7 million antimony trioxide supply deal and strong demand for antimony, which fueled buying despite an 11.3% dip from profit-taking. Executive news, like appointing Shawn Winkler as interim CFO, added volatility but pointed to operational stability. Sector tailwinds from rising antimony prices—due to export restrictions—amplified the gains amid elevated volumes.

What Powered UAMY's +32% Quarterly Performance

The quarterly +32% advance rested on ongoing developments from fiscal 2025 results, which delivered 163% revenue growth to $39.3 million and a 185% increase in gross profit, thanks to higher antimony prices and volumes. The $248 million sole-source contract with the Defense Logistics Agency for antimony ingots over five years solidified UAMY's strategic importance.

Acquisitions such as the Fostung tungsten property—holding 14.77 million tonnes inferred at 0.17% WO3—and restarts at the Stibnite Hill mine strengthened the resource base. Broader U.S. efforts to secure domestic critical minerals amid China restrictions lifted sentiment. Institutional interest and smelter expansions added upward pressure, even with some earnings-related dips.

Why I Rely on Tickeron’s Trending AI Robots

In my research and trading, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots from hundreds available. These bots analyze and trade thousands of tickers across markets using strategies like trend-following, mean reversion, and momentum, from intraday to long-term plays. Metrics such as win rate, profit factor, and Sharpe ratio make it straightforward to pick bots matching my risk tolerance and approach. Updated in real-time, the list spotlights those thriving in current conditions, helping me add automation to my analysis.

UAMY Outlook: Key Factors I'm Watching

One thing that stands out for investors is the Q1 2026 earnings on May 14, including webcast details on antimony deliveries and smelter progress. Keep an eye on execution of the $248 million DLA contract and the $75 million in projected 2026 antimony sales. Trends in critical minerals pricing for antimony and tungsten, amid supply constraints, will be crucial.

I'm watching macro influences like U.S. defense spending, inflation, and import regulations closely. Strategic initiatives—such as ramps in Montana and Alaska mining, Fostung development, and hydrometallurgical joint ventures—could spark further moves. That said, risks like execution delays, commodity swings, and funding needs persist, even with a $91 million cash position. This is important because it underscores the balance between opportunity and volatility in this space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: UAMY

UAMY's RSI Oscillator stays in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in 210 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

UAMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAMY as a result. In 72 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for UAMY turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 48 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAMY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for UAMY entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. UAMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.522) is normal, around the industry mean (12.026). P/E Ratio (98.039) is within average values for comparable stocks, (146.692). UAMY's Projected Growth (PEG Ratio) (9.440) is very high in comparison to the industry average of (1.026). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (17.241) is also within normal values, averaging (283.864).

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 8.52B. The market cap for tickers in the group ranges from 11 to 286.66B. RTNTF holds the highest valuation in this group at 286.66B. The lowest valued company is UNEQ at 11.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was -3%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -24%. MTRN experienced the highest price growth at 22%, while EMAT experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was 71%. For the same stocks of the Industry, the average monthly volume growth was 62% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 76
Price Growth Rating: 68
SMR Rating: 92
Profit Risk Rating: 88
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
UAMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of antimony products

Industry OtherMetalsMinerals

Industry
Metal Fabrication
Address
4438 W. Lovers Lane
Phone
+1 406 606-4117
Employees
101
Web
https://www.usantimony.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).